Pharming Group announces first patient dosed in Phase II clinical trial of leniolisib for common variable immunodeficiency (CVID) with immune dysregulation
Multi-center clinical trial includes sites located in the US, UK and EU…
TREATMENT.COM AI INC. EXTENDS TERM OF MARKETING SERVICES PROVIDED BY I2I MARKETING GROUP
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR…
Brag House Holdings, Inc. Announces Full Exercise of Underwriters Over-Allotment Option
NEW YORK, March 11, 2025 (GLOBE NEWSWIRE) -- Brag House Holdings, Inc.…
LZ Technology Holdings Limited Announces Underwriters Full Exercise of Over-Allotment Option
HUZHOU CITY, China, March 11, 2025 (GLOBE NEWSWIRE) -- LZ Technology Holdings…
Interview on Software Defined Vehicles & Cybersecurity: E/E architecture needs to be rethought
With Software Defined Vehicles (SDVs) relying on computer programmes for day-to-day operations,…
Proteintech Unveils Next-Gen 3D Epitope Mapping to Accelerate Life Science Research
ROSEMONT, Ill.--(BUSINESS WIRE)--#3DEpitopeMapping--Proteintech, a global leader in antibodies and life science solutions,…
Kestra Medical Technologies, Ltd. Announces Pricing of Upsized Initial Public Offering
March 05, 2025 23:03 ET | Source: Kestra Medical Technologies, Ltd. KIRKLAND,…
DealBox Asks If Bitcoin Stuck in the Past? How Its Quietly Becoming a Programmable Blockchain Powerhouse
Palo Alto, CA, March 03, 2025 (GLOBE NEWSWIRE) -- Ethereum showed the…
Jasper Therapeutics Presents Clinical and Preclinical Briquilimab Data at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
REDWOOD CITY, Calif., March 01, 2025 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc.…
Alumis Announces Late-Breaker Psoriasis Presentation of 52-week Phase 2 OLE Data for ESK-001 at 2025 American Academy of Dermatology Annual Meeting and Accelerated Topline Phase 3 Data Readout
– Late-breaking oral presentation to highlight 52-week data of ESK-001 in a…